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Abstract 
Background: Neonatal asphyxia is a respiratory failure during and just after birth. It 
can cause morbidity and mortality in neonates. Interleukin (IL)-6 and IL-1β are 
inflammatory cytokines produced by neuronal cells in early response to brain injury 
due to asphyxia. However, their role in neonatal asphyxia is remain elusive. 
Objective: To determine the association between asphyxia and serumIL-6 and IL-1β 
levels in neonates. 
Methods: Across-sectional study was conducted on neonates diagnosed with 
moderate to severe asphyxia who hospitalized at the Dr. Kariadi General Hospital 
Semarang Indonesia from December 2013 to May 2014. The subjects were examined 
for serum IL-6 and IL-1β. Blood samples were obtained from umbilical vein in the 
first 24 hours of life. Serum IL-6 and IL-1β levels were measured using immunoassay. 
Dependent variable were IL-6 and IL-1β level. Bivariate analysis was performed using 
chi-square test, for the assessment of the association between dependent and 
independent variables. A p-value of less than 0.05 was considered statistically 
significant. 
Result: A total of 54 subjects were enrolled in this study. No significant difference 
between moderate and severe asphyxia neonatesin term of sex, birthweight, type of 
delivery, neonate’s mother age, gestational age, and parity. Levels of IL-6 and IL-1β 
levels wereincreased significantly in both moderate and severe asphyxiagroups, and 
the levels were significant higher in the severe asphyxia than that of in the moderate, 
p=0.003 and p=0.007, respectively. 
Conclusion: There was association between asphyxia and IL-6 and IL-1β levels in 
neonates.IL-6 and IL-1β levels were increased in neonates with moderate and severe 
asphyxia, with extend of increase was significant higher in the later.  
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INTRODUCTION 
 Neonatal asphyxia is a condition of respiratory 
failure during and just after birth. It is a common cause 
of morbidity and mortality in neonate with an estimated 
incidence 1 to 6 per 1,000 baby births and about 4 
million neonates around the world died from severe 
asphyxia each year.1, 2 
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 The imbalance between fetal and maternal blood 
supply causes oxygen supply disturbance and leads to 
hypoperfusion, autoregulation change, and hypoxia. 
Severe hypoxemia decreases adequate oxygen supply to 
several organs including brain, lung, heart, kidney, 
gastrointestinal tract, hematologic system, and muscle, 
and thus may cause organ damage or even death.3-6 
 Asphyxia can cause early inflammatory response and 
significant brain injury in neonates. White matter brain 
injury is the main cause of neurodevelopmental disorder 
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showed that cytokine plays a role in causing hypoxic-
ischemic disorder,7including in response to brain injury.8 
 Pro-inflammatory cytokines increase during acute 
phase after hypoxia.9 Interleukin (IL)-6 and IL-1β are 
pro-inflammatory cytokines produced by astroglia, 
microglia, and progenitor cells oligodendrocytes in 
central nervous system10and released in early response 
of cells injury and inflammation.9The involvement of IL-
6  in a clinical study including preterm newborns in the 
cascade of cerebral injury during perinatal period may 
occurred with or without infection.11IL-6 level in serum 
and brain tissues in the hypoxic-ischemic neonatal rat 
was significantly increased by 6 hours, reached peak by 
24 hours post injury and declining to the baseline level 
by 7 days. The study was conducted in rats model 
underwent left common carotid artery ligation followed 
by 8% O2 and 92% N2 exposure to become hypoxic-
ischemic model.12The role of IL-6  in animal model in 
response to the ischemic-hypoxic after ischemic-
hypoxic insult remains unclear. A study in animal model 
of myocardial infarction showed that IL-6 causes 
myocyte damage mediated by neutrophil.13 On the other 
hand, the role of anti-inflammatory of IL-6 may have 
opposite effect of IL-1β. Recently, IL-6 was found 
having suppression effect on demyelination14 and 
reducing toxicity of N-methyl-D-aspartic acid receptor 
and ischemic damage in vivo in animal.15, 16 
 The mechanism and inflammatory mediator which 
involve in this process remain unclear. Thus, in this 
study, we investigated the IL-6 and IL-1β levels in 
moderate and severe neonatal asphyxia, and found that 
their levels were increased with extend of increase was 
significant higher in severe asphyxia. This study 
examined serum IL-6 and IL-1b from umbilical cord of 
neonates in all gestational age, in one frame of study in 
early 24 hours of life. It therefore enables to identify 
early the severity of hypoxic-ischemic neonatal patients. 
The study can open possibility to use these biomarkers 
for evaluating the treatment and predict the outcome. 
 
MATERIAL AND METHODS 
 This was analytic observational study with a cross-
sectional design. Fifty-four neonates with moderate to 
severe asphyxia who hospitalized in the Dr. Kariadi 
Hospital from December 2013 to May 2014 were 
enrolled the study. The inclusion criteria for the study 
sample were neonates with moderate and severe 
asphyxia and the parents agreed the informed consent. 
Patients with sepsis or infection, suffered from major 
congenital disorders, congenital heart disease, anemia, 
and their mother suffered from infection were excluded 
from the study. Subjects were selected with consecutive 
sampling. This study received ethical approval from 
the Ethic Committee of Faculty of Medicine 
Universitas Diponegoro/ Dr. Kariadi Hospital, and 
conformed to the principles outlined in the Declaration 
of Helsinki.17All legal guardians of the subjects have 
provided written consent to participate in the study. 
 The subjects were examined for serum IL-6 and IL-
1β. Blood samples were obtained from umbilical vein in 
the first 24 hours of life. Serum IL-6 and IL-1β levels 
were measured using ELISA in GAKI Laboratory of 
Universitas Diponegoro University. ELISA kits used for 
IL-6 and IL-1b examination were commercial kits 
purchased from Elabscience (Texas, USA). 
 All study variables were described based on their 
measurement scale. Categorical data were described 
using absolute and relative frequencies (percentage), 
while numerical data were described using mean and 
standard deviation. To assess the association between 
dependent and independent variables, bivariate 
analysis using Chi-square test was conducted.P-value 
< 0.05 was considered as statistically significant. 
Mann Whitney U test was used as alternative test when 




Figure 1. Levels of IL-6 (upper panel) and IL-1β (lower panel) 
(pg/mL) in the moderate and severe asphyxia neonates. Mann 
Whitney test was used for statistical analysis.  
 
RESULTS 
 A total of 54 patients were enrolled in this study. 
Subject characteristics were showed in Table 1. There 
were no significant differences between moderate and 
severe asphyxia neonatesin sex, birthweight,type of 
delivery, mother age, gestational age, and parity.  
 Table 2 showed that IL-6 level in severe asphyxia was 
significantly higher than moderate asphyxia (p<0.001; 
PR=24.0 (95%CI 4.448 – 129.49). The mean of IL-6 was 
also significant higher in the severe asphyxia (p=0.003, 
Figure 1A). The cutoff point between normal and 
abnormal values of IL-6 was 10.2 pg/mL.18The mean of 
 IL-1βwas higher significantly in the severe asphyxia 
than that of the moderate (p=0.0s07, Figure 1B). Table 3 
showed that IL-1βlevel in severe asphyxia was also 
higher significantly (p=0.003; PR=5.786 (95%CI 1.706–
19.621). The cutoff point between normal and abnormal 





























Journal of Biomedicine and Translational Research, 7 (2) 2021, 51-55  
DISCUSSION 
 This was a cross sectional study investigated IL-6 
and IL-1β level in neonatal asphyxia. According to the 
ICD-10 categories, neonatal asphyxia is classified by 
clinical signs and a 1-minute APGAR score category. 
When the 1-minute APGAR score is 0-3, it is classified 
as severe asphyxia. While mild and moderate asphyxia 
is classified when the 1-minute APGAR score is 4-
7.1This study showed that IL-6 and IL-1β level 
significantly increased in both moderate and severe 
asphyxia. Asphyxia affords to activate immune system 
because of hypoxic-ischemic injury.20 IL-6 and IL-1β are 
proinflammatory cytokine released in acute phase of 
inflammatory response in response to hypoxic-ischemic 
brain injury.21-23 
 There were potential markers as predictive factors of 
abnormal outcome in asphyxia. The markers were IL-6, 
IL-1β, and neuron specific enolase (NSE).24Asphyxia 
can cause cells damage if reoxygenation isn’t supplied 
properly.25 In animal study, asphyxia reduced survival 
rate.26, 27 IL-6 and IL-1β were negative predictor for 
outcome in asphyxia.12, 19 
Our study showed that IL-6 level significantly increased 
in both moderate to severe asphyxia. A study reported 
that level of serum IL-6 elevated significantly in 
neonates suffered from asphyxia and developed to 
hypoxic-ischemic encephalopathy (HIE) compared to 
normal group. IL-6 level was predictor for bad outcome 
in HIE.28 
 Measurement of IL-6 level in umbilical cord neonates 
suffered from asphyxia could predict negative outcome 
of asphyxia. Median value of IL-6 level in neonates with 
asphyxia that developed to be HIE increased 376-fold 
higher than normal group. The value increased 5,5-fold 
higher in neonates with asphyxia who didn’t suffer from 
HIE than normal group.9, 18 
 IL-6 level significantly increased in first day of 
neonatal asphyxia compared to control group and 
associated with severity of asphyxia. The elevation of IL-
6 level indicated that this cytokine was potential 
inflammatory marker of asphyxia. IL-6 level decreased 
in third day of asphyxia.29IL-6 level was associated with 
the time of handling sample. Elevation of IL-6 level in 
median value of 17,5 hours after asphyxia and the level 
decreased in median value of 36 hours.30 
 IL-1β level in our study increased in both moderate 
and severe asphyxia. IL-1β level was associated with 
stage of asphyxia.31 Level of IL-1β in severe asphyxia 
significantly higher than moderate asphyxia.32 IL-1β is 
cytokine released by mononuclear cells and macrophages 
in response to infection and tissue injury. IL-1β level in 
neonates with asphyxia significantly increased in the first 
life after injury compared to control group and it was 
associated with poor prognosis.28 
 IL-1β level increased during acute phase of 
inflammation (1-12 hours) after hypoxic-ischemic injury. 
An animal study showed that proinflammatory cytokines 
induced brain damage. IL-1 injection led to neuronal 
Table 1. Subject Characteristics 
Variables 
Grade of asphyxia 
p PR (CI 95%) Severe (20) Moderate (34) 
n % N % 
Sex       
 Male 13 65 13 38.2 0.057€ 3.0 (0.950–9.475) 
 Female 7 35 21 61.8   
Birth weight       
 < 2500 gram 8 40 19 55.9   
 ≥ 2500 gram 12 60 15 44.1 0.260€ 0.526 (0.171 – 1.616) 
Delivery       
 Non-spontaneous 13 65 21 61.8 0.812€ 1.150 (0.364 – 3.631) 
 Spontaneous 7 35 13 38.2   
Mother’s age       
 Risky age 6 30 10 29.4 0.964€ 1.029 (0.307 – 3.442) 
 Un risky age 14 70 24 70.6   
Gestasional age       
 Aterm 9 45 15 44.1 0.950€ 1.036 (0.341 – 3.148) 
 Preterm/posterm 11 55 19 55.9   
Parity       
 Primiparity 15 75 25 73.5 0.905€ 1.080 (0.304 – 3.834) 
 Multiparity 5 25 9 26.5   
       
€Pearson Chi Square test 
 
Tabel 2. IL-6 level in moderate and severe asphyxia 
Grade of Asphyxia 
IL-6 (pg/mL) 
p PR (CI 95%) 
> 10.2 ≤ 10.2 
n % n %   
Severe 12 85.7 8 20 0.000*€ 24.0 (4.448 – 129.49) 
Moderate 2 14.3 32 80   
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death and delayed myelinization in mice babies. A 
review in Italia showed that IL-1β, TNF-α, and neuron 
specific enolase (NSE) were potential biomarker of brain 
damage in neonatal asphyxia.28, 33 
 Asphyxia led to poly (ADP-ribose) polymerase-1 
(PARP-1) overactivity causing energy demand 
elevation, metabolic failure and decreasing NAD+, 
activation of NF-kB signaling pathway subunit p65, 
increased IL-1β and TNF-α, and other proinflammatory 
mediators so and finally it induced cells death in 
mesencephalon of mice with asphyxia. PARP-1 activity 
increased immediately after asphyxia. It reached 
maximum level during 1-8 hours after insult.34Elevation 
of IL-1β, IL-6, and TNF-α in liquor cerebrospinal (LCS) 
of neonates with asphyxia who developed to be HIE. IL-
1β level in LCS was associated with poor outcome in 
neonates with asphyxia.35 
 
CONCLUSION 
 There is association between asphyxia and IL-6 and 
IL-1β levels in neonates.IL-6 and IL-1β levels increase 
in neonates with moderate and severe asphyxia, with 
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